OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Your search returned 8 results. Expanded Search
Genes match for L23767   Similar terms to L23767

   ST3GAL4   (alpha-3-N-acetylneuraminyltransferase;CGS23;FLJ11867;FLJ46764;Gal-NAc6S;NANTA3;SAT3;SAT-3;SIAT4;SIAT4C;SIAT4-C;ST3GalIV;ST-4;STZ;)

Citation  Cited in Publication(s)       15,000 ORF clones at $98 each

|<<     <<      >>     >>|   total pages:0
SKU   Category   Format   Vector   Description   $ Price   Availability  
  TL309077     Human shRNA Lentiviral Plasmid pGFP-C-shLenti ST3GAL4 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector 750 2 Weeks
  TG309077     Human shRNA Retroviral Plasmids pGFP-V-RS ST3GAL4 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector 650 2 Weeks
  TF309077     Human shRNA Retroviral Plasmids pRFP-C-RS ST3GAL4 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector 650 2 Weeks
  TR309077     Human shRNA Retroviral Plasmids pRS ST3GAL4 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector 650 2 Weeks
  SR304374     Human siRNA ST3GAL4 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each 390 2 weeks
  TL511142     Mouse shRNA Lentiviral Plasmid pGFP-C-shLenti ST3GAL4 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector 750 2 Weeks
  TL713844     Rat shRNA Lentiviral Plasmid pGFP-C-shLenti ST3GAL4 - Rat, 4 unique 29mer shRNA constructs in lentiviral GFP vector 750 2 Weeks
SKU   Category   Description   $ Price   Availability  
  KN216090     knockout ST3GAL4 - human gene knockout kit via CRISPR 1200 4 Weeks
Circling Loader
Loading message
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title